Zdrowie i gospodarka · 04/04/1997
FDA Publishes Draft Guideline for Preclinical Testing of Biotechnology-Derived Pharmaceuticals
The FDA is releasing a draft guideline for preclinical testing of biotechnology-derived pharmaceuticals, developed under the ICH framework, to establish internationally acceptable safety evaluation programs for biopharmaceuticals.
Source: Federal Register — Food and Drug AdministrationOpen original release →